Miami, FL, April 18, 2018 -- VITAS® Healthcare, the nation’s leading provider of end-of-life care, will be a contributing sponsor for the America’s Physician Groups national conference, “Taking Responsibility for America’s Health,” held April 19-21, 2018 at the Manchester Grand Hyatt in San Diego.
|
|||
At the conference, VITAS will meet with physician group leaders and independent practice associations to demonstrate the value of hospice and palliative care for their practices. Consistent with the focus of the APG event, VITAS works with patients’ physicians to deliver high-quality care that is also cost-effective— two key factors that define value-based care in today’s healthcare environment.
“Shifting to risk-based care can be daunting for physicians and physician groups. VITAS has 40 years of experience and results in caring for complex, seriously ill patients under capitated, coordinated care models,” says Dr. Alen Voskanian, MD, MBA, VITAS Regional Medical Director for California and a 2017 member of the Health Innovators Fellowship sponsored by the Aspen Institute Global Leadership Network.
"When high- and rising-risk patients can be where they want to be near the end of life, quality rises and costs fall,” he points out. “A VITAS partnership brings an interdisciplinary team, mobile-first technology and care planning strategies that help physicians mitigate risks, reduce costs and improve quality across the continuum of care—key elements of success in today’s healthcare delivery system.”
VITAS representatives will be available at Exhibit Booth 319 during the April 20 Exhibit Fair. Joining Dr. Voskanian at APG will be VITAS medical directors Michael Nisco, MD of San Francisco and Chalat Rajaram, MD of Orange County. In March, Dr. Nisco was named a 2018 Visionary Leader by the American Academy of Hospice and Palliative Medicine.
About VITAS Healthcare
VITAS® Healthcare, a pioneer and leader in the hospice movement since 1978, is the nation’s leading provider of end-of-life care. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 44 hospice programs in 14 states (California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. VITAS employs 11,627 professionals who care for terminally ill patients daily, primarily in the patients’ homes, but also in the company’s 27 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the fourth quarter of 2017, VITAS reported an average daily census of 16,976. Visit www.vitas.com.
Claudia Quintana VITAS Healthcare 877-848-2701 [email protected]


Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
How Marco Pharma International Preserves German Homeopathic Traditions in America 



